Shares of DBV Technologies (DBVT) are moving lower after the company a “substantial doubt regarding its ability to continue as a going concern.” When reporting unaudited results for 2024, DBV said its cash and cash equivalents amounted to $32.5M as of December 31, 2024, compared to $141.4M as of December 31, 2023. The company expects that its cash and cash equivalents “will be sufficient to fund its operations only into April.” DBV intends to seek additional capital as it continues research and development efforts and prepares for the filing of the application and launch of Viaskin Peanut patch, if approved. The stock in late morning trading is down 11%, or 56c, to $4.43.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.